Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ovarian Neoplasms × Circulating Tumor DNA × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Locally Advanced Rectal Carcinoma 1 Gliosarcoma 1 Glioma 1 Genetic Diseases, Inborn 1 Esophageal Neoplasms 1 Circulating Tumor DNA 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Interventions

Carboplatin 275 Paclitaxel 274 Bevacizumab 146 pembrolizumab 88 Gemcitabine 84 liposomal doxorubicin 83 Cyclophosphamide 81 olaparib 75 Cisplatin 75 Topotecan 73 niraparib 52 Docetaxel 48 Doxorubicin 43 Drug Therapy 38 fludarabine 35 Taxes 35 Nivolumab 32 Filgrastim 31 Specimen Handling 28 Etoposide 28 Magnetic Resonance Spectroscopy 25 Peripheral Blood Stem Cell Transplantation 23 durvalumab 22 Immunoglobulin G 21 Disulfides 21 Hyperthermic Intraperitoneal Chemotherapy 20 aldesleukin 19 atezolizumab 18 Oxaliplatin 18 Biopsy 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04846933 2025-01-16

DECIDER

Turku University Hospital

Phase NA Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡